Article citationsMore>>

Joo, Y., Schumacher, B., Landrieu, I., Bartel, M., Smet-Nocca, C., Jang, A., Choi, H.S., Jeon, N.L., Chang, K.A., Kim, H.S., Ottmann, C. and Suh, Y.H. (2015) Involvement of 14-3-3 in Tubulin Instability and Impaired Axon Development Is Mediated by Tau. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 29, 4133-4144.
https://doi.org/10.1096/fj.14-265009

has been cited by the following article:

• TITLE: Structural Basis for the Interaction of 14-3-3β with Tricarboxylic Acid Cycle Intermediate Malate

  AUTHORS: Zhiqiang Hou, Lijing Su, Xiaoyan Liu

  KEYWORDS: Crystal Structure, 14-3-3 Protein, ChREBP, Transcription Activation, Malate, Malic Acid

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.5 No.8, August 3, 2017

  ABSTRACT: The protein family of 14-3-3(s) has risen to a position of higher importance as an adaptor protein in cell biology. The seven highly conserved human 14-3-3 proteins coordinate diverse cellular processes including apoptosis, DNA damage response, protein trafficking, and others. In liver hepatocytes, 14-3-3β binds to Ser196-phosphorilated glucose-responsive carbohydrate response element-binding protein (ChREBP) to inhibit converting excess carbohydrate to fat by regulating the nuclear/cytosol trafficking of ChREBP. Here, we report X-ray crystal structures of homodimeric mammalian 14-3-3β in its apo, Malate-bound forms. The determined apo structure was captured with one monomer in the closed state, whereas the other one had an open conformation. Strikingly, 14-3-3β binds Malate dynamically with a double-closed state, which is distinct from all previously characterized 14-3-3(s) and target ligand-binding modes. Malate docks into a first-time observed cofactor pocket located at the concaved interface of 14-3-3β helices α2, α3, α4 through mainly electrostatic and hydrogen interactions. Such a Tricarboxylic Acid Cycle intermediate Malate bond model might offer a new approach to further analyze insulin-independent 14-3-3/ChREBP pathway of de novo fat synthesis in the liver.